Charles River Laboratories International (CRL) Capital Expenditures Growth (1y) (2010 - 2026)
Powered by 
Analysis
Charles River Laboratories International (CRL) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 31.13% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 291.15% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -31.43% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -11.88% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 20.00% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 6,792.11% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -56.29% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -127.26% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | -11.88% |
| Mar 28, 2026 | -5.76% |
| Dec 27, 2025 | 17.63% |
| Sep 27, 2025 | -8.11% |
| Jun 28, 2025 | -10.61% |
| Mar 29, 2025 | -25.04% |
| Dec 28, 2024 | -3.46% |
| Sep 28, 2024 | -41.28% |
| Jun 29, 2024 | -41.40% |
| Mar 30, 2024 | -25.95% |
| Dec 30, 2023 | -12.02% |
| Sep 30, 2023 | -8.90% |
| Jul 1, 2023 | -18.67% |
| Apr 1, 2023 | 32.82% |
| Dec 31, 2022 | -9.87% |
| Sep 24, 2022 | 30.35% |
| Jun 25, 2022 | 78.44% |
| Mar 26, 2022 | 187.06% |
| Dec 25, 2021 | 12.43% |
| Sep 25, 2021 | 112.09% |